1-12 of 12
Li Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer

Dongbo Xu, Qiang Cao, Li Wang, Jianmin Wang, Bo Xu, Kristopher Attwood, Lei Wei, Yue Wu, Gary J. Smith, Eriko Katsuta, Kazuaki Takabe, Gurkamal Chatta, Khurshid A. Guru, David W. Goodrich, Qiang J. Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (5): 786–798.
DOI: https://doi.org/10.1158/1535-7163.MCT-21-0613
Published: 04 May 2022
View article
PDF
Includes: Supplementary data
Journal Articles

Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress

Antje Lindemann, Ameeta A. Patel, Lin Tang, Noriaki Tanaka, Frederico O. Gleber-Netto, Mason D. Bartels, Li Wang, Daniel J. McGrail, Shiaw-Yih Lin, Steven J. Frank, Mitchell J. Frederick, Jeffrey N. Myers, Abdullah A. Osman
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (7): 1257–1269.
DOI: https://doi.org/10.1158/1535-7163.MCT-20-0252
Published: 01 July 2021
View article
PDF
Includes: Supplementary data
Journal Articles

A Novel Bispecific Antibody with PD-L1–assisted OX40 Activation for Cancer Treatment

Zhihui Kuang, Pu Pu, Min Wu, Zhihai Wu, Li Wang, Yiming Li, Shaofei Zhang, Hua Jing, Weiwei Wu, Bingliang Chen, Junjian Liu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (12): 2564–2574.
DOI: https://doi.org/10.1158/1535-7163.MCT-20-0226
Published: 02 December 2020
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C022: Large scale phenotypic screening using PRISM, integrated with functional genomic screening and transcriptional profiling accelerates target identification of cytotoxic small molecules

Kevin Larpenteur, Lucian de Waal, Li Wang, Mustafa Kocak, Jordan Bryan, Samantha Bender, Sulyman Barkho, Matt Kukurugya, Amy Goodale, Brenton Paolella, Min Cho, James McFarland, Michael Rothberg, Cong Zhu, Colin Trepiccio, Aviad Tsherniak, David Root, Bryson Bennett, Federica Piccioni, Josh Bittker, James Rong, Christopher Mader, David Stokoe, Ari Firestone, Todd R Golub, Jennifer Roth
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C022.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-C022
Published: 01 December 2019
View article
Journal Articles

Abstract B121: An oncogene-linked prodrug strategy in lung cancer

Aaron Boudreau, Jennifer Roth, James Rong, Niclas Olsson, Chris Mader, Jordan Byran, Jordan Rossen, Li Wang, Kevin Larpenteur, Amy Goodale, Colin Trepicchio, Samantha Bender, Aviad Tsherniak, Aravind Subramanian, Mustafa Kocak, Federica Piccioni, Josh Bittker, Cong Zhu, Frank Li, Nick Eriksson, Daphne Koller, Fiona McAllister, Todd Golub, Jeff Settleman, Ari Firestone, David Stokoe
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): B121.
DOI: https://doi.org/10.1158/1535-7163.TARG-19-B121
Published: 01 December 2019
View article
Journal Articles

Auranofin Enhances Ibrutinib's Anticancer Activity in EGFR-Mutant Lung Adenocarcinoma

Jing Hu, Huijuan Zhang, Mengru Cao, Li Wang, Shuhong Wu, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (10): 2156–2163.
DOI: https://doi.org/10.1158/1535-7163.MCT-17-1173
Published: 01 October 2018
View article
PDF
Includes: Supplementary data
Journal Articles

A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2

Zhihong Yang, Angela N. Koehler, Li Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (10): 2294–2301.
DOI: https://doi.org/10.1158/1535-7163.MCT-16-0153
Published: 02 October 2016
View article
PDF
Includes: Supplementary data
Journal Articles

IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells

Haibo Lu, Li Wang, Wen Gao, Jieru Meng, Bingbing Dai, Shuhong Wu, John Minna, Jack A. Roth, Wayne L. Hofstetter, Stephen G. Swisher, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (12): 2864–2873.
DOI: https://doi.org/10.1158/1535-7163.MCT-13-0233
Published: 05 December 2013
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C234: A novel microtubule inhibitor BPR0L075 overcomes paclitaxel resistance in ovarian cancer cell lines

Xinli Liu, Xiaolei Wang, Sean Tedjarati, Tian‐Li Wang, Hsing‐Pang Hsieh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C234.
DOI: https://doi.org/10.1158/1535-7163.TARG-09-C234
Published: 10 December 2009
View article
Journal Articles

Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)

Wei Guo, Shuhong Wu, Li Wang, Rui-yu Wang, Xiaoli Wei, Jinsong Liu, Bingliang Fang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (2): 441–448.
DOI: https://doi.org/10.1158/1535-7163.MCT-08-0839
Published: 11 February 2009
View article
PDF
Includes: Supplementary data
Journal Articles

Expression of the chromatin remodeling factor Rsf-1 in breast carcinoma effusions predicts poor survival

Ben Davidson, Tian-Li Wang, Ie-Ming Shih, Aasmund Berner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B129.
Published: 01 November 2007
View article
Journal Articles

The role of NAC-1 in the development of taxol-resistant ovarian cancers

Natini Jinawath, Kentaro Nakayama, Chanont Vasoontara, Bill Ricketts, Eugene Mechetner, Tian-Li Wang, Ie-Ming Shih
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A201.
Published: 01 November 2007
View article